Look, the problem that I have is not the BS swings with the stock price. Who thinks that in the near future if the stock remains this low, the executives start giving themselves more shares??? The fact is that the volume is anemic during this down turn. It is a fact that the company does not fight for its right to a fair value market cap. Why aren't they coming out swinging? We have the greatest data as it relates to the Alz and Rett that has ever been seen. But here we are with a $600M market cap. It should be in the $3B - $5B range by now and the new Alz data we are waiting for should be taking us up to $4B - $6B at least. Why is this happening? Missling didn't want to play the wall st games. Did not want to give too much of the company away up front. Where has this gotten us? It allowed us to and maybe some smart wall st guys to accumulate over the last 3 years.
We are currently in a binary situation. Either we have great Rett results first that takes us back to the old highs of $31. When I say great results I mean results that will not allow Adam F to knock it down and we get our backing from Wall St accumulating. We need FDA guidance to submit our NDA. Then we hit them with Alz data and the same thing. No BS PR from Missling. Straight data with no conjecture. FDA guidance to submit, KOL's all jumping in to praise the data, etc. Anything short of that we head to $5 pps. If we get all of that we head right to the $6B market cap.
News 
Market Data 
Discover 
